Info@ThinkPinkRocks.com

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

See more here:
FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Share

Leave a Reply